IDEAYA Biosciences Reports $125.7M Third-Quarter Net Loss
IDEAYA Biosciences reported third-quarter 2026 revenue of $10.2 million, down from $207.8 million a year earlier, when results included upfront Servier license revenue. Net loss was $125.7 million versus net income of $119.2 million a year earlier.
IDEAYA Biosciences reported third-quarter 2026 revenue of $10.2 million, down from $207.8 million a year earlier, when results included upfront Servier license revenue. The company posted a net loss of $125.7 million, compared with net income of $119.2 million in the prior-year quarter, and diluted…